跳至主要内容
临床试验/NCT00909064
NCT00909064已完成4 期

The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty

Paul Di Cesare,MD1 个研究点 分布在 1 个国家目标入组 114 人开始时间: 2009年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
114
试验地点
1
主要终点
Number of Days Until a Dry Wound

研究概览

简要总结

The investigators hypothesize that Arixtra patients will be less likely to experience wound infection than patients who have received low-molecular weight heparin, coumadin or aspirin with mechanical compression.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All primary unilateral TKA and THA cases will be included.

排除标准

  • Patients less than 50 kg, Patients with CrCl<30ml/min. Revision and bilateral procedures will be excluded.

研究组 & 干预措施

Arixtra

Experimental

Effect of Arixtra on would drainage and length of stay for the patients with hip and knee replacement

干预措施: Fondaparinux Sodium (Arixtra) (Drug)

结局指标

主要结局

Number of Days Until a Dry Wound

时间窗: Up to 10 days

Days from day of surgery to stoppage of leakage from the wound

次要结局

  • Number of Days in Hospital.(Up to 10 days)
  • Incidence of Wound Infection(Up to 10 days)

研究者

发起方
Paul Di Cesare,MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Paul Di Cesare,MD

Principal Investigator

University of California, Davis

研究点 (1)

Loading locations...

相似试验

The Effects of Arixtra on Wound Drainage Following... | 临床试验